Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Clinical trial NCT04784143 · TERMINATED
Trial details
- NCT number
- NCT04784143
- Sponsor
- Resilient Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-08
- Primary completion
- 2024-06-25
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.